Filing Flows › Orthofix Medical (OFIX) › Q3 FY25
Orthofix Medical (OFIX) Q3 FY25 earnings results (third quarter fiscal 2025)
10-Q filed Nov 4, 2025
Orthofix Medical (OFIX) reported revenue of $206M for the third quarter fiscal 2025 (Q3 FY25), +5% from a year earlier and +1% from the quarter before. Operating margin was -8.3%, net loss $22.8M (11.1% of revenue).
Orthofix Medical, Q3 FY25: revenue $206M (+5% year over year), operating margin -8.3%, net loss $22.8M, operating cash flow $12.4M. The chart follows the revenue to costs, profit and cash.
| Q3 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $206M | +1% | +5% |
| Operating profit | −$17.0M | — | — |
| Net earnings | −$22.8M | — | — |
| Operating cash flow | $12.4M | +7% | +6% |
| Free cash flow | $2.5M | -45% | -57% |
What changed
Revenue was $205.6M in Q3 FY25, up 5% year over year and up 1% from the previous quarter. Global Spine was the largest line at 84% of revenue. Global Spine added $6.0M year over year (up 4%), 66% of the total change.
Gross margin was 72.2%, up 3.5 points from a year earlier. Operating costs exceeded revenue by $17.0M, an operating margin of -8.3%. Operating expenses grew 8% against revenue growth of 5%. The quarter ended with a net loss of $22.8M, wider than the previous quarter's $14.1M loss.
Operating cash flow was $12.4M (up 6% year over year). Non-cash charges added back $12.9M of depreciation and amortization and $7.2M of share-based compensation. Working capital and other items added $15.1M. Capital expenditures of $9.9M left free cash flow of $2.5M.
Questions
What was Orthofix Medical's revenue in the third quarter fiscal 2025?
Orthofix Medical (OFIX) reported revenue of $206M for the third quarter fiscal 2025 (Q3 FY25), +5% from a year earlier and +1% from the quarter before.
Was Orthofix Medical profitable in the third quarter fiscal 2025?
Operating loss was $17.0M (-8.3% of revenue) and net loss $22.8M.
Source: Orthofix Medical 10-Q on SEC EDGAR.